Literature DB >> 15082130

Stability of patient adaptation classifications on the multidimensional pain inventory.

Joan E Broderick1, Doerte U Junghaenel, Dennis C Turk.   

Abstract

This study examined the adaptational classification stability of the multidimensional pain inventory (MPI) in two samples of female fibromyalgia syndrome patients. Retest resulted in one-third of patients being assigned to a different classification. Twenty patients had four repeated MPI assessments over a 10-month period; 85% of them changed classification at least once. Prediction of classification stability using demographic variables and measures of pain, depression, anxiety, impression management, and self-deception was unsuccessful. Examination of the MPI Variable Response Scale and an index of the goodness of fit of the cluster for each patient did not yield sufficient predictive power. The implication of this study is that for a sizable number of chronic pain patients, MPI classifications may not be stable, trait-like characterizations. As such, caution must be applied when treatment is tailored to MPI clusters and when classification change is used as an outcome measure.

Entities:  

Mesh:

Year:  2004        PMID: 15082130     DOI: 10.1016/j.pain.2004.01.014

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  13 in total

1.  [Fibromyalgia syndrome. Rheumatic disease or a mental disorder?].

Authors:  W Häuser
Journal:  Schmerz       Date:  2007-10       Impact factor: 1.107

2.  Improving the usefulness of the Multidimensional Pain Inventory.

Authors:  Jeffrey M McKillop; Warren R Nielson
Journal:  Pain Res Manag       Date:  2011 Jul-Aug       Impact factor: 3.037

3.  Treatment expectation for pain coping skills training: relationship to osteoarthritis patients' baseline psychosocial characteristics.

Authors:  Joan E Broderick; Doerte U Junghaenel; Stefan Schneider; Patricia Bruckenthal; Francis J Keefe
Journal:  Clin J Pain       Date:  2011-05       Impact factor: 3.442

4.  [Psychotherapy in patients with fibromyalgia syndrome].

Authors:  K Thieme; W Häuser; A Batra; K Bernardy; E Felde; M Gesmann; A Illhardt; M Settan; R Wörz; V Köllner
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

5.  Does classification of persons with fibromyalgia into Multidimensional Pain Inventory subgroups detect differences in outcome after a standard chronic pain management program?

Authors:  M L Verra; F Angst; R Brioschi; S Lehmann; F J Keefe; J Bart Staal; R A de Bie; A Aeschlimann
Journal:  Pain Res Manag       Date:  2009 Nov-Dec       Impact factor: 3.037

6.  French translation of the Multidimensional Pain Inventory: L'inventaire multidimensionnel de la douleur.

Authors:  Simon Laliberté; Julie Lamoureux; Michael J L Sullivan; Jean-Marc Miller; Julie Charron; Donald Bouthillier
Journal:  Pain Res Manag       Date:  2008 Nov-Dec       Impact factor: 3.037

7.  Validation of the MPI patient profiles by partners and healthcare providers.

Authors:  Doerte U Junghaenel; Joan E Broderick
Journal:  Pain       Date:  2009-05-01       Impact factor: 6.961

8.  Identification of clusters of individuals relevant to temporomandibular disorders and other chronic pain conditions: the OPPERA study.

Authors:  Eric Bair; Sheila Gaynor; Gary D Slade; Richard Ohrbach; Roger B Fillingim; Joel D Greenspan; Ronald Dubner; Shad B Smith; Luda Diatchenko; William Maixner
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

9.  Using a psychosocial subgroup assignment to predict sickness absence in a working population with neck and back pain.

Authors:  Cecilia Bergström; Jan Hagberg; Lennart Bodin; Irene Jensen; Gunnar Bergström
Journal:  BMC Musculoskelet Disord       Date:  2011-04-26       Impact factor: 2.362

10.  Reliability of the Multidimensional Pain Inventory and stability of the MPI classification system in chronic back pain.

Authors:  Martin L Verra; Felix Angst; J Bart Staal; Roberto Brioschi; Susanne Lehmann; André Aeschlimann; Rob A de Bie
Journal:  BMC Musculoskelet Disord       Date:  2012-08-24       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.